What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma episode artwork

EPISODE · Oct 6, 2023 · 47 MIN

What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

from Oncology Today with Dr Neil Love

Professor Philippe Moreau from the University Hospital of Nantes in France discusses anti-CD38 antibody-based treatment approaches for newly diagnosed and relapsed/refractory multiple myeloma moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here

Episode metadata supplied by the publisher feed · Published Oct 6, 2023

Embed this episode

Ready to play

What Clinicians Want to Know About Anti-CD38 Antibodies in the Management of Multiple Myeloma

0:00 47:30

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Oncology Today with Dr Neil Love?

This episode is 47 minutes long.

When was this Oncology Today with Dr Neil Love episode published?

This episode was published on October 6, 2023.

Can I download this Oncology Today with Dr Neil Love episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!